Searchable abstracts of presentations at key conferences in endocrinology

ea0056p502 | Diabetes therapy | ECE2018

The impact of different glucose-lowering regimens on cardiovascular disease in type 2 diabetes

Vujosevic Snezana , Agic Selim , Borozan Sanja , Vucetic Sanja , Kavaric Sreten , Boskovic Olivera , Djogo Aleksandar , Krnjevic Djordjije , Muzurovic Emir , Madzgalj Dragomir

Introduction: American Heart Association considers diabetes mellitus (DM) to be one of seven major controllable risk factors for cardiovascular disease. At least 68% of patients age 65 or older with DM die from some form of heart disease while 16% die as a consequence of stroke. Studies conducted in patients with type 2 DM (T2DM) have not confirmed a significant association between a certain types of glucose-lowering drugs and a presence of cardiovascular events.<p class="...